January 2019 FDA Recall Bromsite by Sun Pharmaceutical Industries, Inc. (D-0422-2019 - Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.)

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on January 24, 2019 for the product Bromsite. The FDA reported the reason for recall as bromfenac ophthalmic solution, 0.075% (sterile 5 ml) may have a lack of sterility assurance.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0422-2019

Reason for Recall
Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.
Initiated
01-24-2019
Reported
02-06-2019
Quantity
69840 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Sun Pharmaceutical Industries, Inc.
Nationwide within the United States
BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41

Batch or Lot Expiration Information

Lot# : V18E01, Exp. 05/2020

Affected Packages Involved in this Recall